146 related articles for article (PubMed ID: 26002406)
1. Long term antihypertensive drug use and prostate cancer risk: A 9-year population-based cohort analysis.
Pai PY; Hsieh VC; Wang CB; Wu HC; Liang WM; Chang YJ; Wu TN
Int J Cardiol; 2015 Aug; 193():1-7. PubMed ID: 26002406
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
[TBL] [Abstract][Full Text] [Related]
3. The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control study.
Kemppainen KJ; Tammela TL; Auvinen A; Murtola TJ
Cancer Causes Control; 2011 Oct; 22(10):1445-52. PubMed ID: 21769492
[TBL] [Abstract][Full Text] [Related]
4. The risk of hip fracture after initiating antihypertensive drugs in the elderly.
Butt DA; Mamdani M; Austin PC; Tu K; Gomes T; Glazier RH
Arch Intern Med; 2012 Dec; 172(22):1739-44. PubMed ID: 23165923
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort.
Siltari A; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Scand J Urol; 2018; 52(5-6):321-327. PubMed ID: 30698056
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: a longitudinal cohort study.
Jong GP; Chen HY; Li SY; Liou YS
Hypertens Res; 2014 Oct; 37(10):950-3. PubMed ID: 24965171
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing antihypertensive medication compliance in Taiwan: a nationwide population-based study.
Lee CY; Huang CC; Shih HC; Huang KH
Eur J Prev Cardiol; 2013 Dec; 20(6):930-7. PubMed ID: 22689418
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
9. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus.
Johnson ML; Parikh N; Kunik ME; Schulz PE; Patel JG; Chen H; Aparasu RR; Morgan RO
Alzheimers Dement; 2012 Sep; 8(5):437-44. PubMed ID: 22521970
[TBL] [Abstract][Full Text] [Related]
11. Risk of prostate and bladder cancers in patients with spinal cord injury: a population-based cohort study.
Lee WY; Sun LM; Lin CL; Liang JA; Chang YJ; Sung FC; Kao CH
Urol Oncol; 2014 Jan; 32(1):51.e1-7. PubMed ID: 24239459
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies.
Cao L; Zhang S; Jia CM; He W; Wu LT; Li YQ; Wang W; Li Z; Ma J
BMC Urol; 2018 Mar; 18(1):17. PubMed ID: 29514670
[TBL] [Abstract][Full Text] [Related]
13. Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Ann Epidemiol; 2001 Nov; 11(8):534-42. PubMed ID: 11709272
[TBL] [Abstract][Full Text] [Related]
14. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
[TBL] [Abstract][Full Text] [Related]
15. Incidence of ischemic colitis in treated, commercially insured hypertensive adults: a cohort study of US health claims data.
Hines DM; McGuiness CB; Schlienger RG; Makin C
Am J Cardiovasc Drugs; 2015 Apr; 15(2):135-49. PubMed ID: 25559045
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients.
Swindle JP; Buzinec P; Iorga SR; Ramaswamy K; Panjabi S
Curr Med Res Opin; 2011 Sep; 27(9):1719-31. PubMed ID: 21767101
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive drugs and the risk of prostate cancer.
Morote J; Planas J
Eur Urol; 2011 Dec; 60(6):1309-10. PubMed ID: 21962717
[No Abstract] [Full Text] [Related]
18. Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Rodriguez C; Jacobs EJ; Deka A; Patel AV; Bain EB; Thun MJ; Calle EE
Cancer Causes Control; 2009 Jul; 20(5):671-9. PubMed ID: 19067188
[TBL] [Abstract][Full Text] [Related]
19. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
[TBL] [Abstract][Full Text] [Related]
20. Number of daily antihypertensive drugs and the risk of osteoporotic fractures in older hypertensive adults: National health insurance service - Senior cohort.
Kim SY; Kim S; Choi SE; Kim BS; Choi HR; Hwang D; Won CW
J Cardiol; 2017 Jul; 70(1):80-85. PubMed ID: 27884579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
